An analysis of the 2022 DAWN data presents: (1) nationally representative weighted estimates of all drug-related emergency department (ED) visits, (2) nationally representative weighted estimates of the top substances involved in drug-related ED visits, including rates by race and ethnicity; (3) nationally representative weighted estimates of opioid-related ED visits...
Search Results
An analysis of final 2021 DAWN data presents: (1) nationally representative weighted estimates, including percent and unadjusted rates per 100,000, for all drug-related ED visits, (2) nationally representative weighted estimates for the top five drugs in drug-related ED visits, (3) the assessment of monthly trends and drugs involved in polysubstance...
Preliminary Findings from Drug-Related Emergency Department Visits, 2021. An analysis of 2021 preliminary data presents (1) nationally representative weighted estimates for the top five drugs in drug-related ED visits, (2) the assessment of monthly trends and drugs involved in polysubstance ED visits in a subset of sentinel hospitals, and (3)...
This spotlight uses 2013 The Treatment Episode Data Set (TEDS) to examine substance abuse treatment admissions among veterans and nonveterans. Substance abuse treatment admissions were analyzed for alcohol, heroin, cocaine, marijuana, methamphetamine, and other opioids and synthetics.
This is a Treatment Episode Data set (TEDS) Annual Report showing admissions in 2012, and trend data for 2002 to 2012. The report provides information on the demographic and substance abuse characteristics of admissions to treatment aged 12 and older for abuse of alcohol and/or drugs in facilities that report...
The findings in this publication reflect data on drug-related deaths that occurred during calendar year 2010 and were reported by participating medical examiners/coroners (ME/Cs) to DAWN. Data are not nationally representative but cover metropolitan areas in 37 states, with complete data for 13 states. Counts of drug-related deaths for (1)...
This publication presents national estimates of drug-related visits to hospital emergency departments (EDs) for 2010, based on data from the Drug Abuse Warning Network (DAWN). Also presented are comparisons of 2010 estimates with those for 2004, 2008 and 2009. Chapter topics include overall drug misuse and abuse, illicit drugs, alcohol...
Includes the annual report with national estimates of drug-related visits to hospital emergency departments (EDs) for 2011, based on data from the Drug Abuse Warning Network (DAWN); the methodology report, updated for 2011; a glossary of terms updated for 2011, and a guide to the DAWN trend tables (data tables).
This publication presents national estimates of drug-related visits to hospital emergency departments (EDs) for 2011, based on data from the Drug Abuse Warning Network (DAWN). Also presented are comparisons of 2011 estimates with those for 2004, 2009 and 2010. Chapter topics include overall drug misuse and abuse, illicit drugs, alcohol...
This Data Spotlight based on the Treatment Episode Data Set (TEDS) highlights trends in treatment admissions for cocaine among non-Hispanic blacks from 2000 through 2010.
This Data Spotlight from the Treatment Episode Data Set (TEDS) focuses on substance abuse treatment admissions during 2010 among college students who have co-occuring mental disorders.
This Data Spotlight from the Treatment Episode Data Set (TEDS) focuses on substances of abuse among military personnel and veterans aged 21 to 39 who were admitted to substance abuse treatment during 2010.
This report presents data from the Treatment Episode Data Set (TEDS) by Census division and State or jurisdiction for admissions in 2011, and trend data for 2001 to 2011. It provides information on the demographic and substance abuse characteristics of admissions to treatment aged 12 and older for abuse of...
This Drug Abuse Warning Network (DAWN) spotlight is about emergency department visits involving nonmedical use of central nervous system stimulants among adults age 18 to 34 increase between 2005 and 2011.
This Drug Abuse Warning Network (DAWN) spotlight is about emergency department visits involving nonmedical use of phamaceuticals by gender among older adolescents age 12 to 17 from year 2010.